化工社化工社 化学情報印刷レポート · 研究参考用
1,1,1-トリクロロ-2,2,2-トリフルオロエタン
1,1,1-トリクロロ-2,2,2-トリフルオロエタン · 1,1,1-トリクロロトリフルオロエタン · プレシジョンクリーニングエージェント · フレオンFT · 1,1,1-トリフルオロ-2,2,2-トリクロロエタン · 2,2,2-トリクロロ-1,1,1-トリフルオロエタン · フロン113a · フレオン113a

識別子と物理属性
| CAS No. | 26523-64-8 |
|---|---|
| 分子式 | C2Cl3F3 |
| 平均分子量 | 187.37 g/mol |
| 単同位体質量 | 185.9017677 g/mol |
| SMILES | FC(F)(F)C(Cl)(Cl)Cl |
| InChIKey | BOSAWIQFTJIYIS-UHFFFAOYSA-N |
| PubChem CID | 9635 |
| EC No. | 206-564-6 |
| DTXSID | DTXSID5027148 |
| 現地名 | 1,1,1-トリクロロ-2,2,2-トリフルオロエタン |
化学・物理的性質
| XLogP | 3.2 |
|---|---|
| 極性表面積 | 0 |
| 水素結合供与体数 | 0 |
| 水素結合受容体数 | 3 |
| 回転可能結合数 | 0 |
| 重原子数 | 8 |
| 形式電荷 | 0 |
| 複雑度 | 79.5 |
| PFAS | PFAS -> PFAS identified in REACH Regulation EC No. 1272/2008 |
| Solvents | Solvents -> Chlorofluorocarbons |
| SpringerMaterials Properties | 19F nuclear magnetic resonance spectrum |
| 臭い | Expected to be nearly odorless |
| 密度 | 1.5790 g/cu cm at 20 °CDensity: 1.579 g/mL at 20 °C (liquid)1.579 @25 °C1.579 g/mL at 25 °C(lit.) |
| Color/Form | Colorless gas |
| 溶解度 | Soluble in ethanol, chloroform, ethyl etherinsoluble in water8.7mg/L at 25℃ |
| 沸点 | 45.5 °CBP: 45.8 °C at 101.3 kP45.8 °C @760 [mm Hg]45,7°C |
| Decomposition | When heated to decomposition it emits toxic vapors of /hydrogen fluoride and hydrogen chloride/.Under certain conditions, /chlorofluorocarbon/ vapors may decompose on contact with flames or hot surfaces, creating the potential hazard of inhalation of toxic decomposition products. /Chlorofluorocarbon/The appearance of toxic decomposition products serves as warning of the occurrence of thermal decompositon and detection of a sharp acrid odor warns of the presence of these products. /Fluorocarbons/ |
| 融点 | 14.37 °C14.2 °C14°C |
| 蒸気圧 | 360.0 [mmHg]360 mm Hg at 25 °C360 [mm Hg] @25 °C47.87kPa at 25℃ |
| 屈折率 | Index of refraction = 1.3610 at 25 °C/D |
| 引火点 | None |
| ヘンリー定数 | 3.7×10-5 mol/(m3Pa) at 25℃, HSDB (2015) |
| 誘電率 | 2.4399999999999999 |
| InChI | InChI=1S/C2Cl3F3/c3-1(4,5)2(6,7)8 |
| InChIKey | BOSAWIQFTJIYIS-UHFFFAOYSA-N |
| SMILES | C(Cl)(Cl)(Cl)C(F)(F)F |
| LogP(分配係数) | 4.6 at 25℃ |
| CAS データベース | 354-58-5(CAS DataBase Reference) |
| EPAの化学物質情報 | CFC-113a (354-58-5) |
化学的特性
clear colourless liquid
安全性と法規制
| GHS 分類 | WarningH420 (40.8%): Harms public health and the environment by destroying ozone in the upper atmosphere [Warning Hazardous to the ozone layer]P502</a, and a href="https://pubchem.ncbi.nlm.nih.gov/ghs/#P502">P502 (click each P-code to see the statement)Aggregated GHS information provided per 71 reports by companies from 4 notifications to the ECHA C&L Inventory. |
|---|---|
| 規制情報 | Chemical: Ethane, 1,1,1-trichloro-2,2,2-trifluoro-Ethane, 1,1,1-trichloro-2,2,2-trifluoro- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Ethane, 1,1,1-trichloro-2,2,2-trifluoro- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)REACH registered substance: Trichlorotrifluoroethane (EC: 206-564-6) |
| 有害性の概要 | Low acute and chronic toxicityInhalation of high concentrations after a spill or abuse may cause CNS depression and cardiac arrhythmias[HSDB] An irritantInhalation may induce narcosis and incoordination[MSDSonline] See CHLOROFLUOROCARBONS. |
| FDA 要件 | The Food and Drug Administration (FDA), after consultation with the Environmental Protection Agency (EPA), is amending FDA's regulation on the use of ozone-depleting substances (ODSs) in selfpressurized containers to remove the essential-use designations for flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil used in oral pressurized metered-dose inhalers (MDIs). The Clean Air Act requires FDA, in consultation with the EPA, to determine whether an FDA-regulated product that releases an ODS is an essential use of the ODS. FDA has concluded that there are no substantial technical barriers to formulating flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil as products that do not release ODSs, and therefore they will no longer be essential uses of ODSs as of the effective dates of this rule. MDIs for these active moieties containing an ODS may not be marketed after the relevant effective date. DATES: Removal of Part 2.125(e)(2)(iii) and 2.125(e)(4)(vii) is effective June 14, 2010. Removal of Part 2.125(e)(1)(v) and 2.125(e)(4)(iv) is effective December 31, 2010. Removal of Part 2.125(e)(1)(iii) is effective June 30, 2011. Removal of 2.125(e)(2)(iv) and Part 2.125(e)(4)(viii) is effective December 31, 2013. /Ozone-Depleting Substances/ |
用途
使用
CFC 113a has not been offered as a commercial product. It is, however, often present in low levels in CFC 113. It, like CFC 113, is being phased out since it is an ozone-depleting substance.